VarsaAI Launches Sentence Level Referencing: The First AI Capability to Eliminate Hallucination at the Point of Scientific Content Creation

Purpose-built for Medical Affairs, the breakthrough feature links every sentence to a verified source — before content leaves the platform.

VarsaAI, the AI content platform purpose-built for pharmaceutical Medical Affairs teams, today announced the launch of Sentence Level Referencing — a first-to-market capability that eliminates the hallucination risk at the root of AI-generated scientific content by anchoring every sentence to a verified source document before output is produced.

The launch comes at a critical moment for the industry. Peer-reviewed research has established that generic AI poses a systemic accuracy risk to medical communications that is both measurable and severe.

A 2023 study published in Cureus found that 69% of references generated by ChatGPT for medical questions were completely fabricated — yet appeared real, with plausible author names, legitimate journal formats, and convincing PMID numbers. A parallel study from JAMA Network Open (NYU Langone Health, 2024) found that 18% of AI-generated clinical documents contained harmful inaccuracies, including entirely invented data points stated with clinical confidence. Research published in Nature Communications Medicine (2025) identified a further dimension of risk: LLMs do not only invent errors — they amplify errors already present in source material, repeating and elaborating on planted inaccuracies in up to 83% of cases.

For Medical Science Liaisons, medical writers, and the review teams responsible for approving their work, the consequence is not faster content production. It is a materially greater review burden — every reference chased, every data point verified from source, every sentence interrogated for a fabrication that looks identical to a fact.

Sentence Referencing directly addresses this failure mode. Built into VarsaAI's core generation engine, the capability operates at two levels simultaneously: every sentence produced by the platform is traceable to the specific source document from which its content is drawn, and every reference is verified against real, indexed publications before it reaches the user. No phantom citations. No invented endpoints. No confidence-stated figures that have no basis in the uploaded evidence base.

"Generic AI was not designed for environments where a single inaccurate sentence carries regulatory, clinical, and reputational consequences," said Florence Holliday, Co-founder of VarsaAI. "Medical Affairs teams are being sold the productivity promise of AI while quietly absorbing the accuracy liability that comes with it. Sentence Referencing closes that gap. Every sentence has a source. Every source is verified. That is not a feature — it is the foundation that scientific content demands."

VarsaAI is the only AI content platform designed exclusively for pharmaceutical Medical Affairs, enabling teams to produce videos, presentations, and PDF materials at scale without agency dependency. Sentence Referencing is available to all VarsaAI customers with immediate effect.